Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
05/2007
05/01/2007CA2206748C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetylamino)-3-phenylpropionate
04/2007
04/26/2007WO2007047331A1 Process for producing n-halogenated hydrantoins
04/26/2007WO2007046075A1 Piperazine derivatives as antimalarial agents
04/26/2007WO2007045551A2 Renin inhibitors nitroderivatives
04/26/2007WO2006072775A3 Ionic liquids with a cation comprising a basic moiety
04/26/2007WO2005115991A8 Anti-cytokine heterocyclic compounds
04/26/2007US20070093492 Pyrrolidine derivatives
04/26/2007US20070092566 Oral sustained-release tablet
04/26/2007US20070092467 Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers
04/26/2007CA2626568A1 Renin inhibitors nitroderivatives
04/26/2007CA2624166A1 Inhibitors of viral replication
04/26/2007CA2623213A1 Piperazine derivatives as antimalarial agents
04/25/2007EP1776347A1 Sulphonamide derivatives, their preparation and their therapeutic application
04/25/2007EP1478652B1 Components for producing amphoteric liposomes
04/25/2007EP1305294B1 Imidazolyl derivatives
04/25/2007EP1292578B1 Para-aminophenol derivatives and their use as developers for producing oxidation colorations
04/25/2007CN1953965A Novel cis-imidazolines
04/25/2007CN1312120C Adamantane derivatives
04/25/2007CN1312106C Preparation method of water soluble curcumin composition salt
04/25/2007CN1312087C Method for producing molecular compound
04/24/2007US7208628 Compositions and methods for the treatment of hepatitis C virus infection
04/24/2007US7208605 Functionalized ionic liquids, and methods of use thereof
04/24/2007US7208527 Potassium channel modulators
04/24/2007US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
04/24/2007CA2281545C N-heterocyclic derivatives as nos inhibitors
04/24/2007CA2281471C Process for preparing eprosartan
04/24/2007CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007042910A1 Imidazoles and their use as hmg-coa reductase inhibitors
04/19/2007WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases
04/19/2007WO2007042545A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex
04/19/2007WO2007042543A2 Imidazole derivatives and their use for modulating the gaba-a receptor complex
04/19/2007US20070088170 Novel compounds
04/19/2007US20070088069 Novel imidazoles
04/19/2007CA2625974A1 Imidazole derivatives for the treatment of anxiety and related diseases
04/18/2007EP1775289A1 Novel imidazolidine derivatives
04/18/2007EP1773848A2 Salts containing alkoxytris (fluoroalkyl) borate anions
04/18/2007EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors
04/18/2007EP1773785A2 High stability diionic liquid salts
04/18/2007EP1773763A1 Lysine based compounds
04/18/2007EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
04/18/2007EP1773348A2 Tetrapeptide analogs
04/18/2007EP1773326A2 Mitotic kinesin inhibitors
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007CN1950970A Material for electrolytic solution, ionic material-containing composition and use thereof
04/18/2007CN1950343A Basic amine compound and use thereof
04/18/2007CN1950342A Novel compounds as opioid receptor modulators
04/18/2007CN1948314A 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method
04/18/2007CN1310905C Antivirally active heterocyclic azahexane derivatives
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007US7205435 Type B botulism toxin inhibitors
04/17/2007US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007CA2250586C Meta-substituted phenylene sulphonamide derivatives
04/17/2007CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
04/12/2007WO2007041048A2 Synthesis of imidazole-2-thiones via thiohydantoins
04/12/2007WO2007039821A2 Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
04/12/2007WO2007039580A1 Imidazolyl-substituted benzophenone compounds
04/12/2007WO2007039117A2 A process for the preparation of sartan derivatives and intermediates useful in such process
04/12/2007WO2007012670A3 Compounds derived from 5-benzylidene imidazolidine 2,4-dione and their use as mchr-1 antagonists
04/12/2007WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
04/12/2007US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/11/2007EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof
04/11/2007EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
04/11/2007CN1946710A Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
04/11/2007CN1946397A Ion channel modulators
04/11/2007CN1944427A Novel macro-molecular compound, its preparing method and use
04/11/2007CN1944414A Diphenyl-imidazole compound and its preparing method
04/10/2007US7202379 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof
04/10/2007US7202367 Process for arylating or vinylating or alkynating a nucleophilic compound
04/10/2007US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202251 Bicyclic anilide spirohydantoin CGRP receptor antagonists
04/10/2007US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules
04/10/2007CA2379270C External preparation for skin diseases containing nitroimidazole
04/10/2007CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them
04/10/2007CA2337269C Novel method for preparing synthesis intermediates
04/10/2007CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/10/2007CA2175420C Process for the preparation of optionally 2-substituted 5-chloroimidazole-4-carbaldehydes
04/10/2007CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
04/05/2007WO2007038659A1 Violet laser excitable dyes and their method of use
04/05/2007WO2007038359A1 Ionic liquids
04/05/2007WO2007038271A1 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
04/05/2007WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound
04/05/2007WO2007016012A3 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION
04/05/2007WO2006110037A3 Preparation of 2-substituted 4-chl0r0-5-f0rmylimidaz0les by vilsmeier reaction of the condensation product of glycine and an imido ester with a formamide in the presence of a triflate (trifluormethanξsulphonate) catalyst
04/05/2007US20070078229 Dithiocarbamic esters
04/05/2007US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
04/05/2007US20070078120 Novel piperidine derivative
04/05/2007US20070077195 "N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination"
04/05/2007CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound
04/05/2007CA2623245A1 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
04/04/2007EP1770085A1 Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient
04/04/2007EP1768962A1 Method for producing onium salts with a low chloride content
04/04/2007EP1768947A1 Process for the preparation of an (hetero) arylamine
04/04/2007EP1663206B1 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione as non-sedating alpha 2a agonist
04/04/2007EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
04/04/2007CN1942978A Mixture, cation conductor and electrochemical device using those